2m 2m 2m 2m 2m 2m 2m
DOGWOOD THERAP (DWTX)
NASDAQ
$1.70+$0.03 (+1.50%)
Price as of Jun 03, 2026 7:03 PM EDT- $56.8MMarket Cap
- -70.18%1-Year Change
- BiotechnologyIndustry
DOGWOOD THERAP (DWTX)
$1.70+$0.03 (+1.50%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 96,938 +205.15% | -92,192 -161.09% | 150,904 +123.64% | 67,475 +1,089.62% | |
Cost of Revenue | 376,063 +569.85% | 56,141 -45.82% | 103,624 N/A | N/A N/A | |
Gross Profit | -279,125 +88.17% | -148,333 -413.73% | 47,280 -29.93% | 67,475 +1,089.62% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -21.9M +519.28% | -3.5M +104.33% | -1.7M -78.59% | -8.1M -25.25% | |
Depreciation and Amortization Expense | 2,063 -83.06% | 12,177 N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 28.0M +128.74% | 12.2M +124.48% | 5.4M -55.77% | 12.3M -21.26% | |
Operating Profit | -28.0M +128.74% | -12.2M +124.48% | -5.4M -55.77% | -12.3M -21.26% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | -92,192 N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 +100.00% | -92,192 N/A | 0 N/A | 0 -100.00% | |
Total Nonoperating Income and Expense | -6.1M +4,834.04% | -122,979 -181.49% | 150,904 +123.64% | 67,475 +121.13% | |
Income before Taxes | -34.0M +175.59% | -12.4M +133.20% | -5.3M -56.76% | -12.2M -23.26% | |
Income Taxes | 221,096 +44,055.47% | -503 N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -34.3M +177.39% | -12.3M +133.19% | -5.3M -56.76% | -12.2M -23.26% | |
Net Income from Continuing Operations Applicable to Common | -35.5M +176.08% | -12.9M +142.90% | -5.3M -56.76% | -12.2M -23.26% | |
Basic EPS and Net Income | -7.13 -43.05% | -12.52 +4,371.43% | -0.28 -74.77% | -1.11 -42.19% | |
Diluted EPS and Net Income | -7.13 -43.05% | -12.52 +4,371.43% | -0.28 -74.77% | -1.11 -42.19% | |
Basic Weighted Average Shares | 5.0M +384.29% | 1.0M -94.53% | 18.8M +69.62% | 11.1M +32.91% | |
Diluted Weighted Average Shares | 5.0M +384.29% | 1.0M -94.53% | 18.8M +69.62% | 11.1M +32.91% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 6.5M -56.06% | 14.8M +347.64% | 3.3M -52.82% | 7.0M -49.81% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 6.5M -56.06% | 14.8M +347.64% | 3.3M -52.82% | 7.0M -49.81% | |
Total Current Assets | 8.4M -49.04% | 16.5M +297.18% | 4.2M -50.23% | 8.4M -46.95% | |
Accumulated Depreciation | 1,576 0.00% | 1,576 N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 12,754 -24.13% | 16,811 N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | 12,754 -24.13% | 16,811 N/A | N/A N/A | N/A N/A | |
Total Assets | 90.2M -4.39% | 94.3M +2,164.06% | 4.2M -50.23% | 8.4M -46.95% | |
Income Taxes Payable | 12.1M +7.02% | 11.3M +5,147.57% | 215,622 -36.74% | 340,865 -12.60% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 3.1M -3.69% | 3.2M +785.89% | 358,548 -65.63% | 1.0M -18.22% | |
Total Long-Term Debt | 0 N/A | 0 N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 15.4M 0.00% | 15.4M +3,466.68% | 431,244 -36.74% | 681,730 -57.39% | |
Total Liabilities | 15.3M -49.13% | 30.0M +8,274.67% | 358,548 -65.63% | 1.0M -18.22% | |
Retained Earnings | -108.1M +46.41% | -73.8M +20.09% | -61.5M +9.43% | -56.2M +27.88% | |
Total Stockholders Equity | 74.9M +839.77% | -10.1M -365.95% | 3.8M -48.04% | 7.3M -49.48% | |
Total Shares Outstanding | 29.7M +2,132.70% | 1.3M -93.08% | 19.3M +5.06% | 18.3M +120.04% | |
Cash Flow | |||||
Cash from Operating Activities | -15.6M +77.67% | -8.8M +80.49% | -4.9M -57.53% | -11.5M -26.91% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 3.8M 0.00% | 3.8M N/A | N/A N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 7.3M -56.39% | 16.7M +1,344.47% | 1.2M -74.25% | 4.5M +4,700.84% | |
Financials Ratio | |||||
Gross Margin | -287.94% -278.96% | 160.90% +413.53% | 31.33% N/A | N/A N/A | |
Operating Margin | -28,851.89% -317.54% | 13,262.81% +467.44% | -3,609.53% -80.22% | -18,251.66% N/A | |
Return on Assets | -37.14% +48.07% | -25.08% -70.32% | -84.50% -16.71% | -101.45% N/A | |
Return on Equity | -105.78% -127.05% | 390.97% +510.95% | -95.14% -15.23% | -112.22% N/A | |
Revenue Growth | 205.15% +227.35% | -161.09% -230.29% | 123.64% -88.65% | 1,089.62% N/A | |
Current Ratio | 2.76 -47.09% | 5.21 -55.17% | 11.62 +44.81% | 8.02 N/A | |
Cash Ratio | 2.13 -54.37% | 4.67 -49.47% | 9.25 +37.27% | 6.74 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow